Sign in

Labroots Cancer Research

@cancer-lr.bsky.social
8 followers 1 following 92 posts

The Official @labroots.bsky.social Cancer Research Page! We are here to discuss the most recent advances in cancer research and therapeutics. Please join our community!

PostsRepliesMedia
Labroots Cancer Research @cancer-lr.bsky.social · 09/10/2026
Pfizer’s Tukysa wins FDA approval for first-line maintenance treatment of HER2-positive metastatic breast cancer. buff.ly/0cr2xSG
labroots.com
https://www.labroots.com/trending/biotech-and-pharma/31194/pfizer-s-tukysa-approved-first-line-her2-breast-cancer
000
Labroots Cancer Research @cancer-lr.bsky.social · 09/10/2026
Not all multiplex immunofluorescence technologies are designed for the same objective. This guide compares the main categories and explains which workflows are best for discovery, biomarker development, and clinical research. buff.ly/6xVZBFh
labroots.com
Multiplex Immunofluorescence: Matching the Technology to Your Research Goal
000
Labroots Cancer Research @cancer-lr.bsky.social · 07/10/2026
Colorectal cancer in young patients can be especially aggressive, with new research finding that nearly all patients in a large pediatric study had advanced-stage disease at diagnosis. www.labroots.com/trending/dig...
buff.ly
https://buff.ly/9yQwRrZ
000
Labroots Cancer Research @cancer-lr.bsky.social · 06/10/2026
Gene‑modified CAR T cell therapies are transforming cancer treatment, but variability and manufacturing challenges remain. Discover high‑throughput strategies to characterize CAR T cells—activation, memory, exhaustion, cytokines, and killing. buff.ly/kbahSQo
labroots.com
Phenotypic and Functional Characterization of CAR-T Cells to Support Robust Cell Therapy Research
010
Labroots Cancer Research @cancer-lr.bsky.social · 02/10/2026
Missed the live event? No worries. Stream the 2026 Cancer Research and Oncology Virtual Event on demand and explore expert insights and discoveries advancing cancer research. 🎥 Watch for free: buff.ly/wtOKRNb #LRcancer
labroots.com
Watch On-Demand
000
Labroots Cancer Research @cancer-lr.bsky.social · 01/10/2026
Learn how 3D assays can deliver richer data and improve in vitro to in vivo translation: buff.ly/eAfwkoQ
labroots.com
Utilizing a 3D Spheroid Model and Live-Cell Analysis for Compound Profiling
000
Labroots Cancer Research @cancer-lr.bsky.social · 01/10/2026
A new laser-based technique detects the colorectal cancer biomarker CEACAM-5 in blood plasma within minutes, offering much faster results than conventional methods. buff.ly/wUkEBh3
labroots.com
Laser tech detects colorectal cancer biomarker in minutes
000
Labroots Cancer Research @cancer-lr.bsky.social · 01/10/2026
We wish to thank Angela Koker, who is a Sr Manager of Product Specialist for Molecular Biology and Cloning at Thermo Fisher Scientific, for her incredible talk where she demonstrated how Thermo’s Applied Biosystems™ PowerFlex™ Thermal Cycler is helping to advance oncology research. #LRCancer
000
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
HAPPENING SOON! #LRCancer
000
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
We wish to thank Dr. Christoph Schmoelzer, who is the Head of Product Management Advanced Therapeutics & Molecular Diagnostics OEM at Thermo Fisher Scientific, for his incredible talk discussing the latest advancements in molecular oncology. #LRCancer
000
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
HAPPENING SOON! #LRCancer Register here: www.labroots.com/virtual-even...
000
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
We wish to thank Dr. Atocha Romero, who is the Principal Investigator and Director at the Puerta de Hierro University Hospital, for her incredible talk discussing the latest in circulating tumor DNA (ctDNA) research. #LRCancer Register here: www.labroots.com/virtual-even...
000
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
HAPPENING NOW! #LRCancer Register here: www.labroots.com/virtual-even...
000
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
We wish to thank Dr. Olga Vera Puente, who is a Junior Principal Investigator in the Epigenetic Laboratory at the IdiPAZ Hospital Universitario La Paz, for her incredible talk discussing the latest in MAF bZIP Transcription Factor G (MAFG) research. (1/2) #LRCancer
100
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
HAPPENING SOON! #LRCancer Register here: www.labroots.com/virtual-even...
000
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
HAPPENING NOW! #LRCancer Register here: www.labroots.com/virtual-even...
000
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
HAPPENING SOON! #LRCancer Register here: www.labroots.com/virtual-even...
000
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
We wish to thank Dr. Karen Page, who is a Research Fellow at the University of Leicester, for her incredible talk discussing recent advancements in precision oncology. #LRCancer Register here: www.labroots.com/virtual-even...
000
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
HAPPENING SOON! #LRCancer Register here: www.labroots.com/virtual-even...
000
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
HAPPENING NOW! #LRCancer Register here: www.labroots.com/virtual-even...
000
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
We wish to thank Dr. Javier Hernández Losa, who is a Director Molecular Biology Laboratory at the University Hospital Vall d'Hebron, for his incredible talk discussing recent advancements in biomarker testing. (1/2) #LRCancer Register here: www.labroots.com/virtual-even...
100
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
HAPPENING SOON! #LRCancer Register here: www.labroots.com/virtual-even...
000
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
We wish to thank Dr. Janell Richardson, who is the Director of Research and Development (R&D) at Taconic Biosciences, for her incredible talk discussing recent advancements in humanized immune system (HIS) mouse models for cancer research. (1/2)
100
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
HAPPENING NOW! #LRCancer Register here: www.labroots.com/virtual-even...
000
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
HAPPENING NOW! #LRCancer Register here: www.labroots.com/virtual-even...
000
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
We wish to thank Sunil S. Raikar, MD, who is an Associate Professor of Pediatrics at Emory University School of Medicine, for his incredible talk discussing recent advancements in chimeric antigen receptor (CAR) T-cell therapy. #LRCancer Register here: www.labroots.com/virtual-even...
000
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
HAPPENING NOW! #LRCancer Register here: www.labroots.com/virtual-even...
000
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
HAPPENING SOON! #LRCancer Register here: www.labroots.com/virtual-even...
000
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
HAPPENING SOON! #LRCancer Register here: www.labroots.com/virtual-even...
000
Labroots Cancer Research @cancer-lr.bsky.social · 30/09/2026
We wish to thank Dr. Dorothy Sears, who is a Professor in the College of Health Solutions and the John Shufeldt School of Medicine & Medical Engineering at Arizona State University, for her incredible talk discussing intermittent fasting and cancer risk. (1/2) #LRCancer
labroots.com
https://www.labroots.com/virtual-event/cancer-research-oncology-virtual-event-series-2026
100
Labroots Cancer Research @cancer-lr.bsky.social · 29/09/2026
Learn how to generate, monitor, and validate cerebral organoids with a comprehensive 40-day workflow combining live-cell imaging and high-throughput cytometry. Improve reproducibility, quality control, and confidence in neuroscience research. buff.ly/BsKHrXB
labroots.com
Monitoring Cerebral Organoid Development with Imaging and Cytometry
000
Labroots Cancer Research @cancer-lr.bsky.social · 28/09/2026
On Labor Day we discuss occupational cancers and their impact. www.labroots.com/trending/can...
labroots.com
https://www.labroots.com/trending/cancer/31017/impact-occupational-cancers-cancer-burden
001
Labroots Cancer Research @cancer-lr.bsky.social · 27/09/2026
Researchers from Harvard and its affiliated institutions link physical and molecular features of tumor blood vessels to colon cancer prognosis, identifying new tumor signatures for precision medicine treatments. buff.ly/BVetwFN
000
Labroots Cancer Research @cancer-lr.bsky.social · 27/09/2026
Half of melanoma patients do not respond to immunotherapy treatment. Currently, no tools exist to predict who will respond and who will not. In a new study, researchers analyzed patients' blood samples to identify biomarkers that help predict which patients will respond to immunotherapy.
labroots.com
Predicting Melanoma Immunotherapy Treatment Success
011
Labroots Cancer Research @cancer-lr.bsky.social · 25/09/2026
The FDA has approved lirafugratinib (Lyrfigtu) for previously treated advanced cholangiocarcinoma with FGFR2 fusions or rearrangements. buff.ly/I603iRj
labroots.com
https://www.labroots.com/trending/biotech-and-pharma/31111/fda-approves-lirafugratinib-advanced-bile-duct-cancer
000
Labroots Cancer Research @cancer-lr.bsky.social · 25/09/2026
Discover how targeted RNA enrichment and long-read sequencing can help researchers capture more transcript isoforms, improve cell-type resolution, and gain a more complete view of RNA biology. buff.ly/1SOv3G5
labroots.com
Exome-Enriched Single-Nuclei Isoform Sequencing
000
Labroots Cancer Research @cancer-lr.bsky.social · 23/09/2026
Cancer cachexia affects 80% of cancer patients, and a new study shows that exercise may be an effective treatment. Read on to learn how regular exercise may preserve muscle function and overall health long before a cancer diagnosis. buff.ly/cfEVFUV
labroots.com
Exercise Curbs Cancer Cachexia and Tumor Growth in Mice
000
Labroots Cancer Research @cancer-lr.bsky.social · 22/09/2026
Gene‑modified CAR T cell therapies are transforming cancer treatment, but variability and manufacturing challenges remain. Discover high‑throughput strategies to characterize CAR T cells—activation, memory, exhaustion, cytokines, and killing. buff.ly/SxEQwh6
labroots.com
Phenotypic and Functional Characterization of CAR-T Cells to Support Robust Cell Therapy Research
000
Labroots Cancer Research @cancer-lr.bsky.social · 20/09/2026
A new radiation technique called minibeam radiotherapy showed encouraging tumor control and symptom relief in patients with treatment-resistant superficial cancers. buff.ly/nH7vm9M
labroots.com
https://www.labroots.com/trending/cancer/31086/minibeam-radiotherapy-promise-difficult-cancers
000
Labroots Cancer Research @cancer-lr.bsky.social · 19/09/2026
A new pilot study from the Fox Chase Cancer Center uses hydrogel-based dermal regenerative templates to accelerate healing in large, severe skin wounds.
buff.ly
Skin reconstruction method speeds up recovery time
000
Labroots Cancer Research @cancer-lr.bsky.social · 16/09/2026
Programs for determining proper doses for late-stage prostate cancer treatment are currently either fast but inaccurate or precise but too slow. A new study outlines a new AI-biomedical tool that combines the best of both: speed and accuracy. buff.ly/WfYtZxN
000
Labroots Cancer Research @cancer-lr.bsky.social · 15/09/2026
Learn how to generate, monitor, and validate cerebral organoids with a comprehensive 40-day workflow combining live-cell imaging and high-throughput cytometry. Improve reproducibility, quality control, and confidence in neuroscience research. buff.ly/fTI6yxW
labroots.com
Quantifying Cerebral Organoid Differentiation - Application Note
000
Labroots Cancer Research @cancer-lr.bsky.social · 11/09/2026
Discover how targeted RNA enrichment and long-read sequencing can help researchers capture more transcript isoforms, improve cell-type resolution, and gain a more complete view of RNA biology. buff.ly/LbR34Vh
labroots.com
Exome-Enriched Single-Nuclei Isoform Sequencing
010
Labroots Cancer Research @cancer-lr.bsky.social · 11/09/2026
Novo Nordisk’s Wegovy helped 40.4% of children with obesity fall below the clinical obesity threshold after 68 weeks in a phase 3 trial. buff.ly/4FPmuQJ
labroots.com
https://www.labroots.com/trending/biotech-and-pharma/31042/wegovy-promise-children-obesity
000
Labroots Cancer Research @cancer-lr.bsky.social · 11/09/2026
FDA expands Bayer’s Hyrnuo approval to first-line treatment for HER2-mutated NSCLC, after the drug showed a 75% response rate in previously untreated patients. buff.ly/lRXt0XI
labroots.com
https://www.labroots.com/trending/biotech-and-pharma/31041/fda-expands-hyrnuo-her2-mutated-lung-cancer
001
Labroots Cancer Research @cancer-lr.bsky.social · 07/09/2026
On Labor Day we discuss occupational cancers and their impact. www.labroots.com/trending/can...
labroots.com
https://www.labroots.com/trending/cancer/31017/impact-occupational-cancers-cancer-burden
000
Labroots Cancer Research @cancer-lr.bsky.social · 28/08/2026
Half of melanoma patients do not respond to immunotherapy treatment. Currently, no tools exist to predict who will respond and who will not. In a new study, researchers analyzed patients' blood samples to identify biomarkers that help predict which patients will respond to immunotherapy.
labroots.com
Predicting Melanoma Immunotherapy Treatment Success
000
Labroots Cancer Research @cancer-lr.bsky.social · 27/08/2026
A new experimental drug shows promise against a cancer protein thought to be “undruggable” www.labroots.com/trending/can...
labroots.com
https://www.labroots.com/trending/cancer/30959/experimental-drug-targets-undruggable-cancer-protein
000
Labroots Cancer Research @cancer-lr.bsky.social · 24/08/2026
Merck and Moderna's personalized mRNA vaccine combined with Keytruda significantly cuts recurrence and metastasis in advanced melanoma patients. www.labroots.com/trending/can...
labroots.com
Personalized Cancer Vaccine Shows Protects from Melanoma Recurrence | Cancer
Earlier this year, we discussed a collaborative effort between Merck and Moderna, two large biotechnology pharmaceutical companies, to develop a | Cancer
010
Labroots Cancer Research @cancer-lr.bsky.social · 20/08/2026
A new study shows that colorectal cancer causes peripheral nerve damage prior to chemotherapy treatment through tumor-driven inflammation and metabolic changes. www.labroots.com/trending/imm...
labroots.com
Colorectal Cancer Damages Nerves | Immunology And Lymphatic System
Cancer treatment includes an array of different approaches to stop and eliminate tumor progression. While novel therapies are changing the way physicians t | Immunology And Lymphatic System
010